2CBFly-NBOMe

From Self-sufficiency
Jump to: navigation, search
2CBFly-NBOMe
200px
Systematic (IUPAC) name
N-(2-methoxybenzyl)-1-(8-bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b’]difuran-4-yl)-2-aminoethane
Chemical data
Formula C20H22BrNO3
Molar mass 404.297 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

2CBFly-NBOMe (NBOMe-2C-B-FLY) is a compound indirectly derived from the phenethylamine hallucinogen 2C-B, and related to benzodifurans like 2C-B-FLY and N-benzylphenethylamines like NBOMe-2C-I. It was discovered in 2002,[1] and further researched by Ralf Heim at the Free University of Berlin,[2] and subsequently investigated in more detail by a team at Purdue University led by David Nichols.[3] It acts as a potent partial agonist for the 5HT2A serotonin receptor subtype, with a Ki of 0.14nM at the rat 5HT2A receptor.


See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. Elz S, Kläß T, Heim R, Warnke U, Pertz HH. Development of highly potent partial agonists and chiral antagonists as tools for the study of 5-HT2A-receptor mediated function. Naunyn-Schmiedeberg's Archives of Pharmacology. 2002;365:R29.
  2. Ralf Heim PhD. Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts. (German)
  3. Michael Robert Braden PhD. Towards a biophysical understanding of hallucinogen action. Purdue University 2007.